Related Experiment Video

Updated: Mar 8, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K

Manufacturing and clinical applications of non-CAR-T immune effector cells

Thane Kubik1, Theodros Mamo2, David H McKenna3

  • 1Alberta Precision Labs, Calgary, Alberta, Canada.

Transfusion
|March 7, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

19.0K
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
09:30

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

581

Related Experiment Videos

Last Updated: Mar 8, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

19.0K
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
09:30

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

581

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.4K
Overview
85.4K

Articles linked to this work by shared authors, journal, and citation graph.

Human mesenchymal stromal cell extracellular vesicles maintain therapeutic miRNA cargo despite exposure to cystic fibrosis bronchoalveolar lavage fluid.

Cytotherapy·2026

Reprogramming endogenous NK circuits by highly efficient nonviral genome editing.

The Journal of experimental medicine·2026

Quality indicators for cell collections for immune effector cell and gene therapy: recommendations from the American Society for Apheresis.

Cytotherapy·2025

Treatment with Allogeneic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multicenter Phase 2b Clinical Trial (STAT).

American journal of respiratory and critical care medicine·2025

Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers.

Cytotherapy·2025

The lymphocyte function of allogeneic peripheral blood stem cell grafts is associated with relapse and cytomegalovirus reactivation.

Transfusion·2026

Massive fetomaternal hemorrhage and successful prevention of maternal RhD alloimmunization: A case report.

Transfusion·2026

Blood donation practices and perceptions among men who have sex with men in China: A nationwide mixed-methods study.

Transfusion·2026

Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first-time blood donors.

Transfusion·2026

The blood system in Ukraine: Experience in martial law conditions.

Transfusion·2026

Relevance of circulating IgG levels as a marker of health in plasma donors.

Transfusion·2026

Pediatric moyamoya: current evidence and updates in evaluation and management.

Current opinion in pediatrics·2026

Emerging Biomaterials Revolutionizing Pre-Eclampsia Treatment.

Small (Weinheim an der Bergstrasse, Germany)·2026

A pseudovirus-based neutralizing antibody assay for measuring neutralizing antibody against rabies virus.

Journal of clinical microbiology·2026

Coronavirus NSP14 drives internal m7G modification to rewire host splicing and promote viral replication.

Nucleic acids research·2026

Evaluation of Human Serum Albumin Nanoparticles for Rapamycin Delivery.

ACS omega·2026

Dual-Action Nucleic Acid Nanoparticles: Innate Immune Activation and Silver Nanocluster-Mediated Targeting of Intracellular Bacteria.

ACS nano medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us